Bryn Mawr Capital Management LLC lifted its stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 0.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 61,866 shares of the company’s stock after purchasing an additional 164 shares during the period. Bryn Mawr […]